Concepedia
Statistics
Publications
7
Citations
163
H-Index
Active since
2012
Affiliations
Novartis (India)(Current)
Glenmark Pharmaceuticals (India)
Ramachandra Sangana is an author at Novartis (India) specializing in pharmacology, pharmacy, and medicinal chemistry.
Publications per year
2012–2022
Imidazopyridazinones as novel PDE7 inhibitors: SAR and in vivo studies in Parkinson’s disease model
Abhisek Banerjee, S. D. Patil, Mahesh Y. Pawar et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 34 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +16
Genotoxicity evaluation of a valsartan-related complex N-nitroso-impurity
Susanne Glowienke, Ulrich Onken, Azeddine Elhajouji et al. · Regulatory Toxicology and Pharmacology · 2022 · 28 citations
Pharmacy, Pharmacology, Toxicology +14
Evaluation of Clinical Drug Interaction Potential of Clofazimine Using Static and Dynamic Modeling Approaches
Ramachandra Sangana, Helen Gu, Dung Yu Chun et al. · Drug Metabolism and Disposition · 2017 · 27 citations · Full text
Pharmacy, Pharmacokinetics, Pharmacology +17
Discovery of benzo[d]imidazo[5,1-b]thiazole as a new class of phosphodiesterase 10A inhibitors
Abhisek Banerjee, Lakshminarayana Narayana, Firoj A. Raje et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 26 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +7
Isothiazole and isoxazole fused pyrimidones as PDE7 inhibitors: SAR and pharmacokinetic evaluation
Abhisek Banerjee, Pravin S. Yadav, Malini Bajpai et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 23 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +13
1–5 of 7